Global In Vitro Diagnostics (IVD) Market, By Product Type (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Disorders), End User (Hospitals, Laboratories, Homecare Diagnostics, Research Institutes), and Geography - Insights, Opportunity Analysis, and Industry Forecast till 2024

In-vitro Diagnostics (IVD) Market

Diagnostic tools account for considerable share of global healthcare revenue. Its reach ranges from hospitals and clinics to that in research centers. As such, In Vitro Diagnostic (IVD) market share has witnessed increase in recent past, further highlighted its key role in the healthcare industry. IVD has led to cut down in hospital staying costs along with faster diagnosis results. According to the U.S. FDA, in-vitro diagnostic products are those reagents, instruments, and systems intended for use in diagnosis of disease or other conditions, including determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae. Such products are intended for use in the collection, preparation, and examination of specimens taken from the human body.

Over the last decade, the In vitro diagnostics (IVD) market has witnessed substantial growth. However, the growth trajectory witnessed declining motion between 2008 and 2012. The effect was prolonged to 2014 in Europe. Economic downturn in Europe coupled with low healthcare expenditure are factors responsible for marginal demand in IVD. However, as the healthcare growth trajectory is on growth path post-2015, especially in Asia Pacific, the In vitro diagnostics (IVD) market is expected to re-bounce to higher growth trajectory. Also, growing point of care solution is expected to boost the molecular diagnostics, in turn driving growth of the market worldwide.

Though the market competition has heightened with advancement in molecular diagnostics, the market is expected to create lucrative market opportunity for industry players during the forecast period (2016–2024). Growth in the industry will be supported by favorable demographic population, rise in diagnostic centers, and increased healthcare spending along with emerging technologies. Also, the In vitro diagnostics (IVD) market outlook will change with lab automation. As of 2017, the In vitro diagnostics (IVD) market is estimated to account for 33% of global medical devices and diagnostics market and is expected to capture 35% of the market by 2024.  

The global In vitro diagnostics (IVD) market revenue was estimated to be valued at US$ 20,459.3 million in 2016 and is expected to expand at a CAGR of 4.3% during the period 2016 – 2024.

Figure 1. Global In Vitro Diagnostics (IVD) Market Revenue (US$ Million), 2014-2024

in vitro diagnostics market

Source: Coherent Market Insights Analysis (2016)

Infectious diseases has emerged as the highest revenue contributor among application segment

Infectious diseases has emerged as the highest revenue generating application for In vitro diagnostics (IVD) market industry players. The segment is expected to grow by 1.5X at a CAGR of 4.4% between 2016 and 2024. Infectious diseases prevalence has increased considerably in past. Morbidity cases in tuberculosis, salmonella and meningococcal disease was as high as 90,000 in U.S. in 2016. As a result, the demand for IVD from diagnostic centers has increased substantially. As per the Centers for Disease Control and Prevention (CDC), over 3.9 million patients visited hospital outpatient department for infectious and parasitic diseases. Demand for IVD is expected to register fastest growth in detection of autoimmune disorders and infectious diseases.

North America is expected to dominate the market revenue throughout the forecast period

North America is highest contributing region for In vitro diagnostics (IVD) market, with a projected market share of 46.7% by 2024, expanding at the fastest CAGR of 5.4% between 2016 and 2024. Changing healthcare landscape, favorable regulatory policies such as Medicaid and Medicare along with significant healthcare spending (16.7%) is expected to boost the market for IVD in the region. Though the market outlook seems lucrative in North America, reimbursement pressure, increased usage of companion diagnostic and significant growth potential of next generation sequencing (NGS) are key challenges for the industry players in the North America. Companion diagnostics market is proliferating at faster market pace compared to IVD. As such, product innovation in the segment is the key focus area for market players. North America has also seen some of the major mergers and acquisitions in the recent past, to tap into market opportunities. For instance, Roche acquired Ventana Medical in 2008. In 2011, Novartis acquired Genoptix to capture a greater chunk of market in the U.S.

Market players need to invest in R&D and follow inorganic growth to generate high ROI in longer run

Market players are focused towards research and development to expand their business reach in the market. Moreover, industry players are focused towards generating revenue from respective key product segment. For instance, while Roche and Siemens are active players in clinical chemistry IVD product segment, Allere and Abbott holds key market share in point of care IVD solutions. Furthermore, the In vitro diagnostics (IVD) market is expected to witness mergers and acquisition in near future, wherein leading players are expected to acquire regional companies based in emerging economies. Similar trends have been noticed in recent past where leading players acquired/partnered with regional players. For instance, Roche acquired majority stake in Foundation medicine with US$ 1.2 Bn in 2015.

In vitro diagnostics are diagnostic devices and equipment that extract vital information about an individual or patient after a sequence of tests. Introduction of novel diagnostics test applications on the backdrop of advancements and innovations in the IVD technologies by various organizations has resulted in rampant growth of the in vitro diagnostics (IVD) market, which is expected to sustain in the near future. Diagnoses and tests are precursors to any treatment, which makes in vitro diagnostic market highly lucrative. However, majority of the tests are remotely performed making their presence and use unnoticed. Furthermore, increasing elderly population base and rising demand for diagnostic testing is projected to spur growth of the in vitro diagnostics (IVD) market over the forecast period (2016–2024). Also, growing prevalence of diabetes has increased the demand for in vitro diagnostic tests in the recent past, which is further expected to add on to the sales revenue of the in vitro diagnostic market. In 2014, as per National Diabetes Statistics Report 2014, around 9.3% of the population in the U.S. suffered from diabetes and around 28.0% were undiagnosed.

Market Dynamics

Rapid strides made in technology and inclination of healthcare providers towards expanding their product portfolio is fueling growth of this highly lucrative market, especially in emerging economies, which are largely untapped. Furthermore, rise in prevalence of infectious disease globally, especially in Asia Pacific would inadvertently support market growth in the near future. Major organizations in the in vitro diagnostic market are actively focusing on introducing novel technologies in the testing and diagnostic segments of molecular biology. Such initiatives are projected to bring about a rapid shift in the dynamics of in vitro diagnostics (IVD) market, with Asia Pacific taking on the mantle from North America to emerge as the largest market for in vitro diagnostics, owing to latest technologies and uninterrupted investment in the health care sector is expected further to support the growth in in vitro diagnostic market in the near future.

Market Taxonomy

This report segments the global in vitro diagnostics (IVD) market on the basis of product type, application, end user and geography. On the basis of product, the market is categorized into clinical chemistry, immunoassay, diabetes testing, blood testing, molecular diagnostics and others. On the basis of application the market is divided into infectious diseases, diabetes, oncology, cardiology, nephrology, autoimmune disorders and others. On the basis of end user, the market is divided into hospitals, laboratories, homecare diagnostics, research institutes and others. Among all end users, hospitals segment dominated the in vitro diagnostics (IVD) market, owing to rapid advancements in medical systems and developed infrastructure.

Key features of the study:

  • This report provides in-depth analysis of the in vitro diagnostics (IVD) market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 – 2024, considering 2015 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global in vitro diagnostics (IVD) market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
  • Key companies covered as a part of this study Roche Diagnostics, Siemens Healthineers, Abbott Laboratories, Sysmex Corporation, Bio-Rad Laboratories, bioMérieux, Becton, Dickinson and Company and Danaher Corporation
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, market expansion, and marketing tactics
  • The global in vitro diagnostics (IVD) market report caters to various stakeholders in this industry, including investors, device manufacturers, distributors and suppliers for in vitro diagnostics, research and consulting firms, new entrants, and financial analysts
  • Various strategy matrices used in analyzing the in vitro diagnostics (IVD) market would provide stakeholders vital inputs to make strategic decisions accordingly

Detailed Segmentation:

  • Global In Vitro Diagnostics (IVD) Market, By Product Type:
    • Clinical Chemistry
    • Immunoassay
    • Diabetes Testing
    • Blood Testing
    • Molecular Diagnostics
    • Others
  • Global In Vitro Diagnostics (IVD) Market, By Application:
    • Infectious Diseases
    • Diabetes
    • Oncology
    • Cardiology
    • Nephrology
    • Autoimmune Disorders
    • Others
  • Global In Vitro Diagnostics (IVD) Market, By End User:
    • Hospitals
    • Laboratories
    • Homecare Diagnostics
    • Research Institutes
    • Others
  • Global In Vitro Diagnostics (IVD) Market, By Geography:
    • North America
      • U.S.
        • U.S. In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • U.S. In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • U.S. In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
      • Canada
        • Canada In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • Canada In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • Canada In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
    • Europe
      • U.K.
        • U.K In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • U.K In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • U.K In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
      • Germany
        • Germany In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • Germany In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • Germany In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
      • Italy
        • Italy In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • Italy In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • Italy In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
      • France
        • France In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • France In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • France In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
      • Spain
        • Spain In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • Spain In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • Spain In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
      • Russia
        • Russia In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • Russia In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • Russia In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
      • Rest of Europe
        • Rest of Europe In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • Rest of Europe In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • Rest of Europe In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
    • Asia-Pacific
      • China
        • China In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • China In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • China In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
      • India
        • India In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • India In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • India In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
      • Japan
        • Japan In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • Japan In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • Japan In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
      • ASEAN
        • ASEAN In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • ASEAN In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • ASEAN In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
      • Australia
        • Australia In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • Australia In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • Australia In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
      • South Korea
        • South Korea In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • South Korea In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • South Korea In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
      • Rest of Asia Pacific (APAC)
        • Rest of Asia Pacific (APAC) In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • Rest of Asia Pacific In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • Rest of Asia Pacific In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
    • Latin America
      • Brazil
        • Brazil In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • Brazil In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • Brazil In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
      • Mexico
        • Mexico In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • Mexico In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • Mexico In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
      • Rest of Latin America
        • Rest of Latin America In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • Rest of Latin America In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • Rest of Latin America In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
    • Middle East
      • GCC
        • GCC In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • GCC In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • GCC In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
      • Israel
        • Israel In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • Israel In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • Israel In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
      • Rest of Middle East
        • Rest of Middle East In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • Rest of Middle East In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • Rest of Middle East In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
    • Africa
      • North Africa
        • North Africa In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • North Africa In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • North Africa In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
      • Central Africa
        • Central Africa In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • Central Africa In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • Central Africa In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
      • South Africa
        • South Africa In Vitro Diagnostics (IVD) Market, By Product Type:
          • Clinical Chemistry
          • Immunoassay
          • Diabetes Testing
          • Blood Testing
          • Molecular Diagnostics
          • Others
        • South Africa In Vitro Diagnostics (IVD) Market, By Application:
          • Infectious Diseases
          • Diabetes
          • Oncology
          • Cardiology
          • Nephrology
          • Autoimmune Disorders
          • Others
        • South Africa In Vitro Diagnostics (IVD) Market, By End User:
          • Hospitals
          • Laboratories
          • Homecare Diagnostics
          • Research Institutes
          • Others
  • Company Profiles
    • Roche Diagnostics *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
      • Future Plans
    • Siemens Healthineers
    • C. R. Bard, Inc.
    • Abbott Laboratories
    • Sysmex Corporation
    • Bio-Rad Laboratories
    • bioMérieux
    • Becton, Dickinson and Company
    • Danaher Corporation.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet By Product Type
      • Market Snippet By Application
      • Market Snippet By End User
      • Market Snippet By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
        • Supply Side Drivers
        • Demand Side Drivers
        • Economic Drivers
      • Restraints
      • Market Opportunities
    • Regulatory Scenario
    • Industry Trend
    • Merger and Acquisitions
    • New Product Approvals/Launch
    • Promotion and Marketing Initiatives
  4. Global In Vitro Diagnostics Market, By Product Type, 2014 - 2024 (US$ Million)
    • Introduction
      • Market Share Analysis, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, 2014 - 2024
      • Segment Trends
    • Clinical Chemistry
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Diabetes Testing
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Blood Testing
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Molecular Diagnostics
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Other
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
  5. Global In Vitro Diagnostics Market, By Application, 2014 - 2024 (US$ Million)
    • Introduction
      • Market Share Analysis, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, 2014 - 2024
      • Segment Trends
    • Infectious Diseases
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Diabetes
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Oncology
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Cardiology
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Nephrology
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Autoimmune Disorders
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
  6. Global In Vitro Diagnostics Market, By End User, 2014 - 2024 (US$ Million)
    • Introduction
      • Market Share Analysis, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, 2014 - 2024
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Laboratories
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Homecare Diagnostics
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
  7. Global In Vitro Diagnostics Market, By Regions, 2014 - 2024 (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, For Regions, 2014 - 2024
    • North America
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • U.S.
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Canada
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
    • Europe
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • U.K.
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Germany
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Italy
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • France
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Russia
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Rest of Europe
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
    • Asia Pacific
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • China
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • India
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Japan
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • ASEAN
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Australia
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • South Korea
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Rest of Asia Pacific
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
    • Latin America
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • Brazil
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Mexico
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Rest of Latin America
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
    • Middle East
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • GCC Countries
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Israel
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Rest of Middle East
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Portability, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
    • Africa
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • Northern Africa
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • Central Africa
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
        • South Africa
          • Country Trends
          • Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
          • Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
    • Company Profiles
      • Roche Diagnostics
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Siemens Healthineers
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • C. R. Bard, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Sysmex Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Bio-Rad Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • bioMérieux
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Becton, Dickinson and Company
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Danaher Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 42 market data tables and 95 figures on "In Vitro Diagnostics - Global forecast to 2024”.         

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.